newsfilter
← Latest News
Business Wire·

Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France

Launching into this key growth market1 as part of the company's geographic expansion strategy Evolus to provide Nuceiva® to French medical aesthetics healthcare professionals through its partnership with